"Unveiling the Future: Forecasting the In Vitro Diagnostics Market Beyond 2028"
“The In Vitro Diagnostics Market was estimated at USD 100.49 billion in 2021 and is expected to grow at a CAGR of 2.7% during 2022-2028 to reach USD 121.09 billion in 2028”.
North America leads the IVD market with over 40% share in 2021, projected to maintain dominance due to robust healthcare infrastructure, rising chronic diseases, key players presence, while Europe and Asia-Pacific present significant growth prospects.